Adherence to infection prevention and control measures and risk of exposure among health-care workers: A cross-sectional study from the early period of COVID-19 pandemic in Addis Ababa, Ethiopia.
SARS‐CoV‐2
fomite
hygiene
infection‐prevention
Journal
Health science reports
ISSN: 2398-8835
Titre abrégé: Health Sci Rep
Pays: United States
ID NLM: 101728855
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
15
01
2023
revised:
06
06
2023
accepted:
08
06
2023
medline:
26
6
2023
pubmed:
26
6
2023
entrez:
26
6
2023
Statut:
epublish
Résumé
Healthcare workers (HCWs) are considered a high-risk group for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure, ascribed to the amount of time they spend in health-care facilities (HCFs). This study aimed to assess HCWs' compliance with Infection Prevention and Control (IPC) procedures and the risk of exposure during the early period of the pandemic in Addis Ababa, Ethiopia. A descriptive cross-sectional survey was conducted from June to September 2020. With a response rate of 79.2%, a standardized questionnaire was administered among 247 HCWs, working in eight HCFs. Descriptive and multivariate regression analysis was carried out in STATA version 16. About 22.5% (55) of the HCWs had proper adherence to IPC procedures. Of the total participants, 28.2% (69) had proper use of Personal Protective Equipment (PPE), 40% (98) had proper hand hygiene practices, and 33.1% (81) had frequently cleaned their working environment. HCWs who received training on IPC protocols were four times more likely to follow IPC standards than those with no training (adjusted odds ratio [AOR] = 3.93; 95% confidence interval [CI]: 1.46, 10.58). Besides, HCWs working in treatment centers were four times more likely to follow IPC standards than those working in conventional hospitals (AOR = 3.61; 95% CI:1.63, 8.02). Nurses were four times more likely to have adherence to IPC measures than cleaners and runners (AOR = 4.37; 95% CI: 1.38-13.88). The nature and magnitude of the pandemic did not introduce the required degree of adherence to IPC procedures,
Sections du résumé
Background and Aim
UNASSIGNED
Healthcare workers (HCWs) are considered a high-risk group for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure, ascribed to the amount of time they spend in health-care facilities (HCFs). This study aimed to assess HCWs' compliance with Infection Prevention and Control (IPC) procedures and the risk of exposure during the early period of the pandemic in Addis Ababa, Ethiopia.
Methods
UNASSIGNED
A descriptive cross-sectional survey was conducted from June to September 2020. With a response rate of 79.2%, a standardized questionnaire was administered among 247 HCWs, working in eight HCFs. Descriptive and multivariate regression analysis was carried out in STATA version 16.
Results
UNASSIGNED
About 22.5% (55) of the HCWs had proper adherence to IPC procedures. Of the total participants, 28.2% (69) had proper use of Personal Protective Equipment (PPE), 40% (98) had proper hand hygiene practices, and 33.1% (81) had frequently cleaned their working environment. HCWs who received training on IPC protocols were four times more likely to follow IPC standards than those with no training (adjusted odds ratio [AOR] = 3.93; 95% confidence interval [CI]: 1.46, 10.58). Besides, HCWs working in treatment centers were four times more likely to follow IPC standards than those working in conventional hospitals (AOR = 3.61; 95% CI:1.63, 8.02). Nurses were four times more likely to have adherence to IPC measures than cleaners and runners (AOR = 4.37; 95% CI: 1.38-13.88).
Conclusion
UNASSIGNED
The nature and magnitude of the pandemic did not introduce the required degree of adherence to IPC procedures,
Identifiants
pubmed: 37359411
doi: 10.1002/hsr2.1365
pii: HSR21365
pmc: PMC10288972
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e1365Informations de copyright
© 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Int J Gen Med. 2021 May 07;14:1763-1772
pubmed: 33994805
Antimicrob Resist Infect Control. 2020 Aug 17;9(1):136
pubmed: 32807230
PLoS One. 2021 Apr 29;16(4):e0251000
pubmed: 33914826
J Infect Public Health. 2021 Aug;14(8):1051-1064
pubmed: 34174535
Environ Health Insights. 2020 Apr 20;14:1178630220915689
pubmed: 32341652
Asian Pac J Allergy Immunol. 2020 Mar;38(1):10-18
pubmed: 32134278
Front Public Health. 2020 Dec 23;8:573390
pubmed: 33425830
New Microbes New Infect. 2020 Nov;38:100787
pubmed: 33072339
SAGE Open Med. 2021 Jul 29;9:20503121211034389
pubmed: 34377469
Integr Pharm Res Pract. 2020 Aug 24;9:105-112
pubmed: 32904494
J Prev Med Hyg. 2021 Sep 15;62(3):E605-E612
pubmed: 34909486
Lancet Glob Health. 2020 Jun;8(6):e780-e789
pubmed: 32389195
Risk Manag Healthc Policy. 2021 Mar 25;14:1299-1310
pubmed: 33790675
Ann Intern Med. 2020 Jun 2;172(11):766-767
pubmed: 32176257
Trop Med Health. 2021 Apr 16;49(1):30
pubmed: 33863397
J Environ Public Health. 2020 Oct 30;2020:6021870
pubmed: 33178291
Cochrane Database Syst Rev. 2020 Apr 21;4:CD013582
pubmed: 32315451
Am J Infect Control. 2018 Nov;46(11):1211-1217
pubmed: 29866633
Allergy Asthma Clin Immunol. 2021 Oct 16;17(1):109
pubmed: 34656181
Infect Drug Resist. 2021 Feb 02;14:381-390
pubmed: 33564246
J Hosp Infect. 2007 Aug;66(4):346-51
pubmed: 17662505
Risk Manag Healthc Policy. 2020 Aug 24;13:1327-1334
pubmed: 32922101
Biomed Res Int. 2020 Dec 04;2020:5917378
pubmed: 34031643
PLoS One. 2021 Nov 18;16(11):e0260270
pubmed: 34793560
BMC Infect Dis. 2022 Mar 16;22(1):261
pubmed: 35296265
Indian J Med Microbiol. 2020 Apr-Jun;38(2):139-143
pubmed: 32883925
Ethiop J Health Sci. 2018 Mar;28(2):177-186
pubmed: 29983515
BMC Infect Dis. 2021 May 27;21(1):490
pubmed: 34044784
Sci Rep. 2018 Mar 23;8(1):5119
pubmed: 29572463
PLoS One. 2021 Mar 9;16(3):e0248272
pubmed: 33690704
One Health. 2020 Feb 24;9:100124
pubmed: 32195311
Clin Infect Dis. 2020 Nov 19;71(16):2109-2113
pubmed: 32409825
BMC Infect Dis. 2021 May 19;21(1):454
pubmed: 34011263
Pak J Med Sci. 2020 May;36(COVID19-S4):S99-S103
pubmed: 32582323
PLoS One. 2021 Jan 14;16(1):e0245469
pubmed: 33444417
J Clin Nurs. 2012 May;21(9-10):1466-75
pubmed: 21777312
SAGE Open Med. 2022 May 20;10:20503121221098238
pubmed: 35646356
BMJ Glob Health. 2021 Jun;6(6):
pubmed: 34083244
Drug Healthc Patient Saf. 2021 Feb 16;13:37-46
pubmed: 33623439